Alnylam Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.
ALNY Key Statistics
Stock Snapshot
The current Alnylam Pharmaceuticals(ALNY) stock price is $464.45, with a market capitalization of 61.36B. The stock trades at a price-to-earnings (P/E) ratio of 1968.76.
During the trading session on 2025-12-05, Alnylam Pharmaceuticals(ALNY) shares reached a daily high of $473.50 and a low of $464.45. At a current price of $464.45, the stock is 0.0% higher than the low and still -1.9% under the high.
Trading volume for Alnylam Pharmaceuticals(ALNY) stock has reached 34.68K, versus its average volume of 1.07M.
Over the past 52 weeks, Alnylam Pharmaceuticals(ALNY) stock has traded between a high of $495.55 and a low of $205.87.
Over the past 52 weeks, Alnylam Pharmaceuticals(ALNY) stock has traded between a high of $495.55 and a low of $205.87.
ALNY News
Alnylam Pharmaceuticals (ALNY) has quietly extended its strong run, with the stock up about 12% over the past month and nearly doubling over the past year, invi...
As the U.S. stock market wraps up a strong week, with major indices like the S&P 500 and Dow Jones Industrial Average extending their winning streaks, investors...
Below is Validea's guru fundamental report for ALNYLAM PHARMACEUTICALS, INC. (ALNY). Of the 22 guru strategies we follow, ALNY rates highest using our Twin Mome...
Analyst ratings
68%
of 31 ratingsMore ALNY News
Earlier this quarter, Carillon Tower Advisers highlighted Alnylam Pharmaceuticals after the company's launch of vutrisiran for transthyretin amyloidosis surpass...